Compare Cassava Sciences Inc (FLNA) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Open Text Corporation — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Open Text Corporation trades at $23.47 (market cap $5.45B). The key difference: Open Text Corporation is far larger — about 102.6× Cassava Sciences Inc's market cap, and Open Text Corporation pays a 4.84% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | OTEX | |
|---|---|---|
Market Cap | $53.14M | $5.45B |
Sector | Health | Technology |
52-Week High | $4.64 | $39.69 |
52-Week Low | $1.09 | $20.01 |
Enterprise Value | -$33.43M | $10.61B |
Dividend Yield | — | 4.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
OpenText (OTEX) trades at $22.76, showing modest daily gains. The stock presents a mixed picture: technical indicators are bearish, but fundamental valuation metrics appear attractive with a P/E of 11.04 and EV/EBITDA of 6.63. The company has consistently beaten earnings expectations in recent quarters and is executing a strategic shift, divesting non-core assets like Vertica while investing in AI and cloud capabilities in Europe. Operating cash flow remains strong at $831M for 2025.
The outlook is cautiously optimistic. The primary opportunity lies in the stock's apparent undervaluation relative to its cash flow and the strategic repositioning towards high-growth AI and cloud segments. Key risks include execution of the new CEO's organic growth plan, competitive pressures in enterprise software, and the stock's current bearish technical momentum which may persist in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
